Daily non-political popular news in brief.

Men who are continually active at work may have a decreased risk of prostate cancer

Men with jobs that require them to be physically active may be getting benefits beyond salary and health insurance -- they may be at a decreased risk of developing prostate cancer, according to a study at UCLA's Jonsson Cancer Center.

Read more »

Keywords: men, continually, active, work, decreased, risk, prostate, cancer

« Previous | Next »

Similar news on "Men who are continually active at work may have a decreased risk of prostate cancer":

1. Soy found protective against localized prostate cancer
   03-15-2007 · EurekAlert!
   The largest study examining the relationship between the traditional soy-rich Japanese diet and development of prostate cancer in Japanese men has come to a seemingly contradictory conclusion: Intake of isoflavone chemicals, derived largely from soy foods, decreased the risk of localized prostate cancer but increased the risk of advanced prostate cancer.
   Similar news · Read more »
   
2. Just 4 months of hormone therapy can delay prostate cancer growth by up to 8 years
   01-02-2008 · EurekAlert!
   Researchers report that just four months of hormonal therapy before and with standard external beam radiation therapy slowed cancer growth by as much as eight years -- especially the development of bone metastases -- and increased survival in older men with potentially aggressive prostate cancer. This "neoadjuvant" hormonal therapy may allow men most at risk of developing bone metastases avoid long-term hormonal therapy later on.
   Similar news · Read more »
   
3. Online tool supports more dialogue on prostate cancer risk
   02-04-2008 · EurekAlert!
   A comprehensive, clinical nomogram tool, the Sunnybrook Prostate Cancer Risk Calculator -- the first to use all known risk factors for prostate cancer -- is available online to help men determine individual prostate cancer risk in consultation with their primary care physician. A nomogram is a statistical model to determine risk for disease based on risk factors using a table and chart format.
   Similar news · Read more »
   
4. Vitamin D, variations in its receptor and prostate cancer
   03-19-2007 · EurekAlert!
   Results of this study by Haojie Li and colleagues suggest that vitamin D deficiency is common among men in the US, and that vitamin D status and genetic variation in the VDR gene affect prostate cancer risk.
   Similar news · Read more »
   
5. Statin use linked with decreased prostate cancer mortality rates, lower PSA levels
   05-20-2007 · EurekAlert!
   In recent years, research has indicated a possible link between dietary fat intake and prostate cancer. Research presented today at the 102nd Annual Scientific Meeting of the American Urological Association explores the effect statin medications (which work to reduce low-density lipoprotein, or LDL, levels) may have on prostate-specific antigen, the incidence of prostate cancer, and mortality due to prostate cancer.
   Similar news · Read more »
   
6. Generic prostate drug helps find high-risk cancers early
   09-11-2007 · EurekAlert!
   Finasteride is a well-known generic drug that shrinks an enlarged prostate. A large 2003 study showed it also reduces men's risk of getting prostate cancer. A new study in the Journal of the National Cancer Institute suggests finasteride also increases the chances that physicians will find fast-growing prostate cancers early.
   Similar news · Read more »
   
7. Prostate cancer therapy may increase risk of death from heart disease in older men
   02-24-2007 · EurekAlert!
   Androgen deprivation therapy -- one of the most common treatments for prostate cancer -- may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.
   Similar news · Read more »
   
8. Analysis: Older men treated for early prostate cancer
   12-12-2006 · EurekAlert!
   An analysis of Surveillance, Epidemiology and End Results-Medicare records for 44,630 older men suggests surgery or radiation therapy for early-stage prostate cancer increased the lifespan of men between 65 and 80 years old compared to observation, sometimes known as "watch and wait." The study supported a benefit of treatment even for men whose disease had a low risk of spreading, and even if they were elderly men (75 to 80 years old).
   Similar news · Read more »
   
9. Radiation seed implant decreases risk of death over watchful waiting
   10-31-2007 · EurekAlert!
   Prostate cancer patients cut their risk of dying of the disease in half when they receive radiation seed implants to treat their cancer, compared to those who don't receive active treatment, within six months from being diagnosed with localized prostate cancer, according to a study presented Oct. 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
   Similar news · Read more »
   
10. Adding radiation therapy for treatment of advanced prostate cancer may offer benefit
    11-14-2006 · EurekAlert!
    Treating advanced prostate cancer with radiation therapy after removal of the prostate gland reduces the risk of disease recurrence, but does not appear to significantly improve the length of survival, according to a study in the Nov. 15 issue of JAMA, a theme issue on men's health.
    Similar news · Read more »